Immuron (IMRN) Return on Assets (2018 - 2025)
Immuron's quarterly Return on Assets came in at 5039936256.33% in Q3 2025, up 503993625633.0% year-on-year from N/an in Q3 2024, and up 119.26% quarter-over-quarter from 2298576329.98% in Q2 2025.
Immuron has reported Return on Assets for 8 years, with the latest figure at 5039936256.33% in Q3 2025.
- For the quarter ending Q3 2025, Return on Assets rose 503993625633.0% year-over-year to 5039936256.33%; the trailing twelve-month figure through Sep 2025 stood at 5039936256.33% (up 503993625633.0% YoY), and the FY2025 full-year result was 0.01%, down 1.0% from the prior year.
- Return on Assets for Q3 2025 stood at 5039936256.33%, up from 2298576329.98% in the prior quarter.
- The five-year high for Return on Assets was 5039936256.33% in Q3 2025, with the low at 0.0% in Q4 2023.
- Average Return on Assets over 5 years is 816489249.64%, with a median of 0.0% recorded in 2021.
- Year-over-year, Return on Assets changed 0 bps in 2021 and soared 2000000000 bps in 2025.
- Tracing IMRN's Return on Assets over 5 years: stood at 0.0% in 2021, then jumped by 64 bps to 0.0% in 2022, then tumbled by 29127 bps to 0.0% in 2023, then surged by 2000000000 bps to 4092336908.65% in 2024, then gained by 23 bps to 5039936256.33% in 2025.
- The last three Return on Assets figures came in at 5039936256.33% (Q3 2025), 2298576329.98% (Q2 2025), and 4092336908.65% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -0.01% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -0.01% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.00% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.00% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.00% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.00% |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | 5,039,936,256.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 5,039,936,256.33% |
| Jun 30, 2025 | 2,298,576,329.98% |
| Dec 31, 2024 | 4,092,336,908.65% |
| Sep 9, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 28, 2023 | 0.00% |
| Aug 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Aug 31, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 1, 2020 | 0.00% |
| Jun 30, 2020 | -0.01% |
| Dec 31, 2019 | -0.01% |
| Jun 30, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Jun 30, 2018 | 0.01% |